Clinical Trial Update: LOSE-AF: Can Weight Loss Help Patients With Atrial Fibrillation? [NA]

View source ↗

Summary

The LOSE-AF trial, sponsored by the University of Oxford, studied whether weight loss could benefit patients with atrial fibrillation and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Obesity

Snippet

Sponsor: University of Oxford | Conditions: Atrial Fibrillation, Overweight and Obesity | NA | Status: COMPLETED